Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.

Ítems similars

• 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
  per: Coleman, R. E., et al.
  Publicat: (1987)
• Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
  per: Coleman, R. E., et al.
  Publicat: (1988)
• Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl(2)MDP) on Rat Macrophage-mediated Bone Resorption In Vitro
  per: Reitsma, Pieter H., et al.
  Publicat: (1982)
• In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation.
  per: de Vries, E, et al.
  Publicat: (1982)
• Paget's disease of the orbit: before and after APD.
  per: Buckler, H M, et al.
  Publicat: (1987)